Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis

OBJECTIVE: To assess the relationship between use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and the risk of gout among patients with type 2 diabetes mellitus (T2DM). METHODS: A systemic review and meta-analysis were designed by reviewing articles published between 2000 January 1 and 2022...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Shih-Wei, Hwang, Bing-Fang, Kuo, Yu-Hung, Liu, Chiu-Shong, Liao, Kuan-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242385/
https://www.ncbi.nlm.nih.gov/pubmed/37288295
http://dx.doi.org/10.3389/fendo.2023.1158153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242385/
https://www.ncbi.nlm.nih.gov/pubmed/37288295
http://dx.doi.org/10.3389/fendo.2023.1158153

Ejemplares similares